Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_assertion description "[Activating mutations in the phosphoinositide-3-kinase (PI3K)/AKT/mTOR pathway are present in the majority of breast cancers and therefore are a major focus of drug development and clinical trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_assertion evidence source_evidence_literature NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_assertion SIO_000772 23888070 NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_assertion wasDerivedFrom befree-20150227 NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_assertion wasGeneratedBy ECO_0000203 NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.
- befree-20150227 importedOn "2015-02-27" NP623519.RAbyZ57HP0iWa-9ocH4Me9EjDJ8D0fnmr0MsH1FByVAmo130_provenance.